Neutrophil elastase depends on serglycin proteoglycan for localization in granules

Blood

Volumn 109, Issue 10, 2007, Pages 4478-4486

  Niemann, Carsten U ^a,e   Åbrink, Magnus ^b   Pejler, Gunnar ^b   Fischer, Rikke L ^c   Christensen, Erik I ^d   Knight, Stefan D ^b   Borregaard, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c STATENS SERUM INSTITUT   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; GELATINASE; LEUKOCYTE ELASTASE; MESSENGER RNA; MYELOBLASTIN; PROTEOGLYCAN; SERGLYCIN PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL VIRULENCE; BONE MARROW CELL; CELL ACTIVITY; CELL ASSAY; CELL GRANULE; CELL MATURATION; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LOCALIZATION; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KLEBSIELLA PNEUMONIAE; KNOCKOUT MOUSE; MOUSE; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; WESTERN BLOTTING; WILD TYPE;

EID: 34248398513     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-02-001719     Document Type: Article

References (61)

1. Lominadze G, Powell DW, Luerman GC, et al. Proteomic analysis of human neutrophil granules. Mol Cell Proteomics. 2005;4:1503-1521.
2. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5:1317-1327.
3. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503-3521.
4. Gombart AF, Koeffler HP. Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBP(epsilon). Curr Opin Hematol. 2002;9:36-42.
5. Segal AW. Variations on the theme of chronic granulomatous disease. Lancet. 1985;1:1378-1383.
6. Le Cabec V, Cowland JB, Calafat J, Borregaard N. Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc Natl Acad Sci U S A. 1996;93:6454-6457.
7. Grujic M, Braga T, Lukinius A, et al. Serglycin-deficient cytotoxic T-lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem. 2005;280:33411-33418.
8. Robinson MS. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004;14:167-174.
9. Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell. 1999;3:11-21.
10. Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet. 2003;35:90-96.
11. Kantheti P, Qiao X, Diaz ME, et al. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron. 1998;21:111-122.
12. Feng L, Seymour AB, Jiang S, et al. The beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet. 1999;8:323-330.
13. Cavarra E, Martorana PA, Cortese S, et al. Neutrophils in beige mice secrete normal amounts of cathepsin G and a 46 kDa latent form of elastase that can be activated extracellularly by proteolytic activity. Biol Chem. 1997;378:417-423.
14. Cui SH, Tanabe F, Terunuma H, et al. A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity. Clin Exp Immunol. 2001;125:283-290.
15. Kolset SO, Prydz K, Pejler G. Intracellular proteoglycans. Biochem J. 2004;379:217-227.
16. Kolset SO, Gallagher JT. Proteoglycans in haemopoietic cells. Biochim Biophys Acta. 1990;1032:191-211.
17. Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem. 2004;279:40897-40905.
18. Humphries DE, Wong GW, Friend DS, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature. 1999;400:769-772.
19. Forsberg E, Pejler G, Ringvall M, et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature. 1999;400:773-776.
20. Raja SM, Wang B, Dantuluri M, et al. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem. 2002;277:49523-49530.
21. Niemann CU, Cowland JB, Klausen P, et al. Localization of serglycin in human neutrophil granulocytes and their precursors. J Leukoc Biol. 2004;76:406-415.
22. Borregaard N, Sehested M, Nielsen BS, Sengelov H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 1995;85:812-817.
23. Bjerregaard MD, Jurlander J, Klausen P, Borregaard N, Cowland JB. The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow. Blood. 2003;101:4322-4332.
24. Cowland JB, Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol. 1999;66:989-995.
25. Klausen P, Niemann CU, Cowland JB, Krabbe K, Borregaard N. On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur J Haematol. 2005;75:332-340.
26. Tkalcevic J, Novelli M, Phylactides M, et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12:201-210.
27. Lennartsson A, Pieters K, Vidovic K, Gullberg U. A murine antibacterial orthologue to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow. J Leukoc Biol. 2005;77:369-377.
28. Birn H, Verroust PJ, Nexo E, et al. Characterization of an epithelial approximately 460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptor-associated protein. J Biol Chem. 1997;272:26497-26504.
29. Wright CD, Kennedy JA, Zitnik RJ, Kashem MA. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Biochem Biophys Res Commun. 1999;254:614-617.
30. Nakajima K, Powers JC, Ashe BM, Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem. 1979;254:4027-4032.
31. Macdonald SJ, Dowle MD, Harrison LA, et al. Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151). J Med Chem. 2002;45:3878-3890.
32. Hof P, Mayr I, Huber R, et al. The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J. 1996;15:5481-5491.
33. Fujinaga M, Chernaia MM, Halenbeck R, Koths K, James MN. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol. 1996;261:267-278.
34. Kleywegt G, Zou J, Kjeldgaard M, Jones T. Crystallography of biological macromolecules. In: Rossmann M, Arnold E, eds. International Tables for Crystallography. Volume F. Dordrecht, Holland: Kluwer Academic Publishers; 2001:353-368.
35. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991;47(pt 2):110-119.
36. DeLano WL. The PyMOL Molecular Graphics System. 2002. Available at: http://www.pymol.org. Accessed November 2005.
37. Rao NV, Marshall BC, Gray BH, Hoidal JR. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am J Respir Cell Mol Biol. 1993;8:612-616.
38. Stevens RL, Humphries DE, Wong GW. Serglycin proteoglycans: the family of proteoglycans stored in the secretory granules of certain effector cells of the immune system. In: Iozzo RV, ed. Proteoglycans: Structure, Biology, and Molecular Interactions. New York, NY: Marcel Dekker; 2000:177-200.
39. Theilgaard-Monch K, Jacobsen LC, Borup R, et al. The transcriptional program of terminal granulocytic differentiation. Blood. 2005;105:1785-1796.
40. Kostoulas G, Horler D, Naggi A, Casu B, Baici A. Electrostatic interactions between human leukocyte elastase and sulfated glycosaminoglycans: physiological implications. Biol Chem. 1997;378:1481-1489.
41. Frimodt-møller N, Knudsen JD, Espersen F. The mouse peritonitis/sepsis model. In: Sande M, Zak O, eds. Handbook of Animal Models of Infection: Experimental Models in Antimicrobial Chemotherapy. San Diego, CA: Academic Press; 1999:127-136.
42. Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med. 1998;4:615-618.
43. Stevens RL, Otsu K, Austen KF. Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. J Biol Chem. 1985;260:14194-14200.
44. Razin E, Stevens RL, Akiyama F, Schmid K, Austen KF. Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6- disulfate. J Biol Chem. 1982;257:7229-7236.
45. Lemansky P, Gerecitano-Schmidek M, Das RC, Schmidt B, Hasilik A. Targeting myeloperoxidase to azurophilic granules in HL-60 cells. J Leukoc Biol. 2003;74:542-550.
46. Walsh RL, Dillon TJ, Scicchitano R, McLennan G. Heparin and heparan sulphate are inhibitors of human leucocyte elastase. Clin Sci (Lond). 1991;81:341-346.
47. Frommherz KJ, Faller B, Bieth JG. Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor. J Biol Chem. 1991;266:15356-15362.
48. Marossy K. Interaction of the chymotrypsin- and elastase-like enzymes of the human granulocyte with glycosaminoglycans. Biochim Biophys Acta. 1981;659:351-361.
49. Antonilli L, Paroli E. Role of the oligosaccharide inner core in the inhibition of human leukocyte elastase by chondroitin sulfates. Int J Clin Pharmacol Res. 1993;13(suppl):11-17.
50. Baici A, Salgam P, Fehr K, Boni A. Inhibition of human elastase from polymorphonuclear leucocytes by a glycosaminoglycan polysulfate (Arteparon). Biochem Pharmacol. 1980;29:1723-1727.
51. Baici A, Bradamante P. Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interact. 1984;51:1-11.
52. Gullberg U, Lindmark A, Lindgren G, et al. Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J Biol Chem. 1995;270:12912-12918.
53. Lindmark A, Gullberg U, Olsson I. Processing and intracellular transport of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U-937-modulation by brefeldin A, ammonium chloride, and monensin. J Leukoc Biol. 1994;55:50-57.
54. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317-2322.
55. Aprikyan AA, Dale DC. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol. 2001;13:535-538.
56. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet. 1999;23:433-436.
57. Massullo P, Druhan LJ, Bunnell BA, et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood. 2005;105:3397-3404.
58. Horwitz M, Benson KF, Duan Z, Li FQ, Person RE. Hereditary neutropenia: dogs explain human neutrophil elastase mutations. Trends Mol Med. 2004;10:163-170.
59. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996;381:77-80.
60. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 1996;381:75-77.
61. Ponnambalam S, Baldwin SA. Constitutive protein secretion from the trans-Golgi network to the plasma membrane. Mol Membr Biol. 2003;20:129-139.